1,2-dipalmitoylphosphatidylcholine has been researched along with Carcinoma, Pancreatic Ductal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Deng, A; Fang, X; Gu, M; Kong, J; Liu, P | 1 |
1 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Nano-biotinylated liposome-based immunoassay for the ultrasensitive detection of protein biomarker in urine.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Biomarkers, Tumor; Biotinylation; Carcinoma, Pancreatic Ductal; Cholesterol; DNA; Humans; Immunoassay; Limit of Detection; Liposomes; Lithostathine; Nucleic Acid Amplification Techniques; Pancreatic Neoplasms; Reproducibility of Results | 2018 |